Fuller & Thaler Asset Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-276,455
Closed -$2.41M 553
2021
Q3
$2.41M Sell
276,455
-1,175
-0.4% -$10.7K 0.02% 330
2021
Q2
$2.83M Sell
277,630
-7,205
-3% -$76.1K 0.02% 313
2021
Q1
$3.4M Buy
+284,835
New +$3.23M 0.02% 284
2019
Q1
Sell
-294,200
Closed -$1.91M 486
2018
Q4
$1.91M Buy
294,200
+500
+0.2% +$3.82K 0.03% 269
2018
Q3
$2.44M Buy
+293,700
New +$2.23M 0.03% 287
2016
Q2
Sell
-136,500
Closed -$1.92M 860
2016
Q1
$1.92M Buy
+136,500
New +$1.41M 0.04% 183

Other funds holding NPTN

Fuller & Thaler Asset Management's NPTN Position: Q4 2021 in Review

Fuller & Thaler Asset Management sold out of NEOPHOTONICS CORP (NPTN) in Q4 2021, closing a stake of 276,455 shares — an estimated $2.41M sold.

Fuller & Thaler Asset Management first reported a position in NPTN in Q1 2016 and held it in 6 quarters. The position peaked at $3.4M in Q1 2021. 145 funds tracked by Wall St. Rank hold NPTN as of Q4 2021.

  • Fuller & Thaler Asset Management reported no remaining NEOPHOTONICS CORP position as of Q4 2021 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 276,455 NEOPHOTONICS CORP shares in Q4 2021, an estimated $2.41M.
  • Fuller & Thaler Asset Management first reported a position in NEOPHOTONICS CORP in Q1 2016 and held it in 6 quarters.
  • Fuller & Thaler Asset Management's NEOPHOTONICS CORP position peaked at $3.4M in Q1 2021.
  • 145 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2021.

Based on Fuller & Thaler Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.